Merck Gains FDA Label Update for WINREVAIR in PAH
RAHWAY, N.J. — September 22, 2026 Merck announced that the U.S. Food and Drug Administration (FDA) has approved an...
FDA
Advertisement
AstraZeneca Gains US Priority Review for IMFINZI in MIBC
WILMINGTON, Del. — September 25, 2026 AstraZeneca announced that the US Food and Drug Administration (FDA) has accepted and...
Altasciences Supports 4B Healthcare’s RhineX Clinical Advance
LAVAL, Québec — September 24, 2026 Altasciences announced that its formulation development, manufacturing and quality support for 4B Healthcare...
AC Immune Reports Positive Week-100 VacSYn Phase 2 Data
LAUSANNE, Switzerland — September 23, 2026 AC Immune SA reported positive safety and immunogenicity results through Week 100 from...
ANI Gains FDA Approval for Everolimus Oral Suspension Tablets
PRINCETON, N.J. — September 23, 2026 ANI Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted...
Advertisements
Filana Gains FDA Lift of Simufilam Clinical Hold
AUSTIN, Texas — September 22, 2026 Filana Therapeutics announced that the U.S. Food and Drug Administration has lifted the...
Quoin Gains FDA Fast Track for QRX003 in Peeling Skin Syndrome
ASHBURN, Va. — September 22, 2026 Quoin Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Fast...
Palisade Bio Gains FDA IND Clearance for PALI-2108
DENVER, Colo. — September 22, 2026 Palisade Bio announced that the U.S. Food and Drug Administration has cleared the...
Traferox Gains FDA Clearance for X°Port Heart System
MISSISSAUGA, Ontario — September 22, 2026 Traferox Technologies Inc. announced that the U.S. Food and Drug Administration has granted...
MAIA Advances Phase 3 Ateganosine Trial in Advanced NSCLC
CHICAGO — September 22, 2026 MAIA Biotechnology announced that enrollment has reached 65 patients in the pivotal Phase 3...
Advertisement
